Strongbridge Biopharma plc (NASDAQ: SBBP) stock is on Today Watch List

Last week, Strongbridge Biopharma plc (NASDAQ: SBBP) price decreased by -2.22%. The stock price over the past three months has declined by -23.08%. Within the past six months, the stock has lost -23.08%, and over the past year, it has lost -9.47%.


Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.

Sponsored


Latest Highlights

In a statement released on Sept. 8, 2021, Strongbridge Biopharma plc (NASDAQ: SBBP) announced that its shareholders voted to approve Xeris Pharmaceutical’s (NASDAQ: XERS) proposed acquisition of Strongbridge. The transaction was supported by at least 99 percent of votes cast at both a special court-ordered meeting of shareholders as well an extraordinary general meeting of shareholders, representing (in each case) approximately 67 percent of the outstanding shares eligible to vote at the Strongbridge shareholder’s meetings on September 8, 2021, in Pennsylvania, United States. As part of the transaction, the businesses of Xeris and Strongbridge will become a single entity called Xeris Biopharma Holdings, Inc. (“Xeris Biopharma Holdings” or “HoldCo”).

About the Company

As a global biopharmaceutical company focused on developing and commercializing therapies for rare diseases, Strongbridge Biopharma plc is in the commercial stage of development. One of Strongbridge’s rare endocrine therapies is RECORLEV® (levoketoconazole), currently under review by the FDA for endogenous Cushing’s syndrome treatment and veldoreotide extended-release, a pre-clinical somatostatin analog being investigated to treat acromegaly and for other conditions that could be affected by somatostatin receptor activation.

 

 

Latest

The Chart for Block Inc. (SQ) Stock Is Flashing Mixed Signals

In the first quarter, large investment funds expanded their...

What to Expect When Snap Inc. (SNAP) Reports Quarterly Earnings?

Snapchat, a social media platform owned by Snap Inc....

Getting Sustainable Earnings? Movado Group Inc. (MOV)

Movado Group Inc. (NYSE: MOV), the owner of the...

Future Prospects Brighter For Red Cat Holdings Inc. (RCAT) Stock

The US Army has awarded Red Cat Holdings, Inc....

Newsletter

 

Don't miss

Healthy Upside Potential: Maxar Technologies Ltd. (MAXR)

In May 25 trading, shares of space business Maxar...

Atkore Inc. (ATKR) stock: Better Than You Think

Atkore Inc. (NYSE:ATKR), a manufacturer of infrastructure, electrical, and...

Provention Bio, Inc. (PRVB) Having a Robust Premarket After Abysmal Thursday

Provention Bio, Inc. (PRVB), a clinical stage biopharmaceutical company,...

Farmmi, Inc. (FAMI) Stock Soaring in Premarket, Here’s the Reason

Farmmi, Inc. (FAMI), a company that processes and sells...

Ulta Beauty Inc. (ULTA) last month performance of -6.16% certainly makes it a sizzling prospect

Ulta Beauty Inc. (NASDAQ: ULTA) open the trading on May 26, 2022, with great promise as it jumped 7.09% to $377.96. During the day,...

The key reasons why Alset EHome International Inc. (AEI) is -95.54% away from 52-week high?

Witnessing the stock’s movement on the chart, on May 26, 2022, Alset EHome International Inc. (NASDAQ: AEI) set off with pace as it heaved...

StoneCo Ltd. (STNE) latest performance of 2.97% is not what was on cards

StoneCo Ltd. (NASDAQ: STNE) established initial surge of 2.97% at $9.71, as the Stock market unbolted on May 26, 2022. During the day, the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here